Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (401-410 of 679) with videos related to

Pageof 68
Sort By:
Medicine|December 5, 2023
Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational studyAyako Maeda-Minami, Ayako Kawamoto, Tetsuhiro Yoshino, et al.
Frontiers in Human Neuroscience|July 26, 2022
Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching AnalysisTaisuke Yatomi, Takahito Uchida, Akihiro Takamiya, et al.
Scientific Reports|August 3, 2022
Identifying neurocognitive disorder using vector representation of free conversationToshiro Horigome, Kimihiro Hino, Hiroyoshi Toyoshiba, et al.
Neuropsychiatric Disease and Treatment|April 17, 2019
Relationships between Internet addiction and clinicodemographic and behavioral factorsMuhammad ElSalhy, Takahiro Miyazaki, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Journal of Affective Disorders|June 18, 2013
Time course for memory dysfunction in early-life and late-life major depression: a longitudinal study from the Juntendo University Mood Disorder ProjectHitoshi Maeshima, Hajime Baba, Yoshiyuki Nakano, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Individual Prediction of Remission Based on Clinical Features Following Electroconvulsive Therapy: A Machine Learning ApproachKazuki Nakajima, Akihiro Takamiya, Takahito Uchida, et al.
International Journal of Geriatric Psychiatry|September 4, 2025
Pareidolic Illusions and Associated Lower Regional Gray Matter Volumes in Community-Dwelling Older Adults Without Dementia: The Arakawa 65+ StudyHana Nishida, Shogyoku Bun, Ryo Shikimoto, et al.
Schizophrenia Bulletin|December 22, 2012
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trialsTaishiro Kishimoto, Alfred Robenzadeh, Claudia Leucht, et al.
Pageof 68

Showing results (401-410 of 679) with videos related to

Sort By:
Pageof 68
Medicine|December 5, 2023
Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational studyAyako Maeda-Minami, Ayako Kawamoto, Tetsuhiro Yoshino, et al.
Frontiers in Human Neuroscience|July 26, 2022
Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching AnalysisTaisuke Yatomi, Takahito Uchida, Akihiro Takamiya, et al.
Scientific Reports|August 3, 2022
Identifying neurocognitive disorder using vector representation of free conversationToshiro Horigome, Kimihiro Hino, Hiroyoshi Toyoshiba, et al.
Neuropsychiatric Disease and Treatment|April 17, 2019
Relationships between Internet addiction and clinicodemographic and behavioral factorsMuhammad ElSalhy, Takahiro Miyazaki, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Journal of Affective Disorders|June 18, 2013
Time course for memory dysfunction in early-life and late-life major depression: a longitudinal study from the Juntendo University Mood Disorder ProjectHitoshi Maeshima, Hajime Baba, Yoshiyuki Nakano, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Individual Prediction of Remission Based on Clinical Features Following Electroconvulsive Therapy: A Machine Learning ApproachKazuki Nakajima, Akihiro Takamiya, Takahito Uchida, et al.
International Journal of Geriatric Psychiatry|September 4, 2025
Pareidolic Illusions and Associated Lower Regional Gray Matter Volumes in Community-Dwelling Older Adults Without Dementia: The Arakawa 65+ StudyHana Nishida, Shogyoku Bun, Ryo Shikimoto, et al.
Schizophrenia Bulletin|December 22, 2012
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trialsTaishiro Kishimoto, Alfred Robenzadeh, Claudia Leucht, et al.
Pageof 68